Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure

被引:15
作者
Oikonomou, Evangelos [1 ]
Siasos, Gerasimos [1 ]
Tousoulis, Dimitris [1 ]
Kokkou, Eleni [1 ]
Genimata, Vasiliki [1 ]
Zisimos, Konstantinos [1 ]
Latsios, George [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, Hippokration Hosp, Cardiol Dept 1, GR-11527 Athens, Greece
关键词
Biomarkers; heart failure; microRNA; myocardial hypertrophy; prognosis; treatment; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; IN-VIVO; EXPRESSION; BIOMARKERS; DYSREGULATION; SIGNATURE; STRESS;
D O I
10.2174/15680266113139990104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
MicroRNAs are a class of evolutionarily small non-coding RNAs of 19 to 25 nucleotides in length, that represent one of the most exciting areas of current medical science as they can regulate a complex regulatory network of gene expression and physiologic processes including differentiation, proliferation and apoptosis in a highly context dependent fashion. Recently, their role in cardiovascular disease and in the regulation of cardiomyocyte size and function, in the action potential, in angiogenesis and in mitochondrial function was recognized. Importantly, they have been evaluated for their prognostic and diagnostic role in heart failure and modification of specific microRNAs levels has been tested as a therapeutic option in experimental heart failure models. In this review article we refer the most emerging evidence, concerning the role of microRNAs in myocardial development in heart failure pathophysiology and prognosis, and their therapeutic implications.
引用
收藏
页码:1548 / 1558
页数:11
相关论文
共 95 条
[1]  
Alba AC, 2012, EXPERT REV CARDIOVAS, V10, P167, DOI [10.1586/erc.11.178, 10.1586/ERC.11.178]
[2]   Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: A randomized placebo-controlled study [J].
Andreou, Ioannis ;
Tousoulis, Dimitris ;
Miliou, Antigoni ;
Tentolouris, Costas ;
Zisimos, Kostas ;
Gounari, Panagiota ;
Siasos, Gerasimos ;
Papageorgiou, Nikos ;
Papadimitriou, Christos A. ;
Dimopoulos, Meletios-Athanasios ;
Stefanadis, Christodoulos .
ATHEROSCLEROSIS, 2010, 210 (01) :194-198
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Angiotensin Receptor Type 1 Single Nucleotide Polymorphism 1166A/C is Associated With Malignant Arrhythmias and Altered Circulating miR-155 Levels in Patients With Chronic Heart Failure [J].
Blanco, Raul R. ;
Austin, Harland ;
Vest, Richard N., III ;
Valadri, Ravinder ;
Li, Wei ;
Lassegue, Bernard ;
Song, Qing ;
London, Barry ;
Dudley, Samuel C. ;
Bloom, Heather L. ;
Searles, Charles D. ;
Zafari, A. Maziar .
JOURNAL OF CARDIAC FAILURE, 2012, 18 (09) :717-723
[5]   MicroRNA-133 controls cardiac hypertrophy [J].
Care, Alessandra ;
Catalucci, Daniele ;
Felicetti, Federica ;
Bonci, Desiree ;
Addario, Antonio ;
Gallo, Paolo ;
Bang, Marie-Louise ;
Segnalini, Patrizia ;
Gu, Yusu ;
Dalton, Nancy D. ;
Elia, Leonardo ;
Latronico, Michael V. G. ;
Hoydal, Morten ;
Autore, Camillo ;
Russo, Matteo A. ;
Dorn, Gerald W., II ;
Ellingsen, Oyvind ;
Ruiz-Lozano, Pilar ;
Peterson, Kirk L. ;
Croce, Carlo M. ;
Peschle, Cesare ;
Condorelli, Gianluigi .
NATURE MEDICINE, 2007, 13 (05) :613-618
[6]   National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 [J].
Chen, Jersey ;
Normand, Sharon-Lise T. ;
Wang, Yun ;
Krumholz, Harlan M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15) :1669-1678
[7]   Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure [J].
Chen, Jian-Fu ;
Murchison, Elizabeth P. ;
Tang, Ruhang ;
Callis, Thomas E. ;
Tatsuguchi, Mariko ;
Deng, Zhongliang ;
Rojas, Mauricio ;
Hammond, Scott M. ;
Schneider, Michael D. ;
Selzman, Craig H. ;
Meissner, Gerhard ;
Patterson, Cam ;
Hannon, Gregory J. ;
Wang, Da-Zhi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (06) :2111-2116
[8]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[9]   microRNAs in heart disease: putative novel therapeutic targets? [J].
Condorelli, Gianluigi ;
Latronico, Michael V. G. ;
Dorn, Gerald W., II .
EUROPEAN HEART JOURNAL, 2010, 31 (06) :649-658B
[10]   MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis [J].
Corsten, Maarten F. ;
Papageorgiou, Anna ;
Verhesen, Wouter ;
Carai, Paolo ;
Lindow, Morten ;
Obad, Susanna ;
Summer, Georg ;
Coort, Susan L. M. ;
Hazebroek, Mark ;
van Leeuwen, Rick ;
Gijbels, Marion J. J. ;
Wijnands, Erwin ;
Biessen, Erik A. L. ;
De Winther, Menno P. J. ;
Stassen, Frank R. M. ;
Carmeliet, Peter ;
Kauppinen, Sakari ;
Schroen, Blanche ;
Heymans, Stephane .
CIRCULATION RESEARCH, 2012, 111 (04) :415-U155